The project National Jewish Health chose to work with was designed to be a PI CME intervention that began in June 2012. Supported by an unrestricted educational grant from GlaxoSmithKline, it aims to improve the care of patients with atopic dermatitis (AD) in a pediatric network of clinics by educating the healthcare team on best practice tools, providing resources, and helping the clinics redesign their practices. Before the end of 2012, it was approved for MOC Parts II and IV.

The PI CME initiative, based on an identified practice gap and area of need for improvement in the treatment of pediatric patients who have the chronic inflammatory and prurific skin disease at the Metro Denver area Rocky Mountain Youth Clinics, began by conducting a baseline needs assessment. They worked collaboratively with the clinics to understand the barriers they face in caring for their patients with AD, reviewed AD care best practices, and developed a checklist for AD patient visits.

The intervention itself began with a half-day multidisciplinary training that included both lecture and hands-on activities. Physicians at the clinics filled out a self-assessment following a live training in September. ABP had several elements that had to be included to satisfy its Part II requirements, Meadows says. She reported the assessment design to the ABP board, which approved it for 10 MOC Part II points. The points were automatically credited to the participating providers’ ABP profiles once they completed the assessment with an established passing rate.